Zylox-Tonbridge is starting to show signs that its medical devices are moving from overseas buzz to real use in hospitals, with doctors trying multiple products across several countries. If those early wins turn into repeat buying, it could help the company rely less on a tough, price-pressured home market—but the next steps will matter.Read more